AAAAAA
Results:
1-7
|
Results: 7
Authors:
Marstaller, B
Lersch, C
Berger, H
Helmberger, H
Hellerhoff, P
Schulte-Frohlinde, E
Citation: B. Marstaller et al., Hepatocellular carcinoma, extension into the right atrium per continuitatem, DEUT MED WO, 125(13), 2000, pp. 391-394
Authors:
Eckel, F
Lersch, C
Assmann, G
Schulte-Frohlinde, E
Citation: F. Eckel et al., Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tractcancer, ANN ONCOL, 11(6), 2000, pp. 762-763
Authors:
Eckel, F
Lersch, C
Lippl, F
Assmann, G
Schulte-Frohlinde, E
Citation: F. Eckel et al., Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer, J EXP CL C, 19(3), 2000, pp. 295-300
Authors:
Schulte-Frohlinde, E
Reindl, W
Bierling, D
Lersch, C
Brantl, V
Teschemacher, H
Schusdziarra, V
Citation: E. Schulte-frohlinde et al., Effects of oral casokefamide on plasma levels, tolerance, and intestinal transit in man, PEPTIDES, 21(3), 2000, pp. 439-442
Authors:
Eckel, F
Lersch, C
Erdmann, J
Schmidt, B
Schulte-Frohlinde, E
Citation: F. Eckel et al., A 42-year-old man with hemolytic-uremic syndrome associated with gemcitabine therapy for adenocarcinoma of the liver, Z GASTROENT, 38(7), 2000, pp. 593-596
Authors:
Eckel, F
Lersch, C
Huber, W
Weiss, W
Berger, H
Schulte-Frohlinde, E
Citation: F. Eckel et al., Multimicrobial sepsis including Clostridium perfringens after chemoembolization of a single liver metastasis from common bile duct cancer, DIGESTION, 62(2-3), 2000, pp. 208-212
Authors:
Lersch, C
Eckel, F
Sader, R
Paschalidis, M
Zeilhofer, F
Schulte-Frohlinde, E
Theiss, W
Citation: C. Lersch et al., Initial experience with Healthport miniMax (R) and other peripheral arm ports in patients with advanced gastrointestinal malignancy, ONCOL-BASEL, 57(4), 1999, pp. 269-275
Risultati:
1-7
|